Listed

BeOne Medicines Ltd.

ONCNasdaqCIK 1651308HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.71bn, Q2 FY2026
Operating income$325.0m, Q2 FY2026
Net income$237.0m, Q2 FY2026
BeOne Medicines Ltd., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m781Revenue, Q3 FY2023, three months to 2023-09-30$781.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure634Revenue, Q4 FY2023, three months to 2023-12-31$634.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure752Revenue, Q1 FY2024, three months to 2024-03-31$751.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure929Revenue, Q2 FY2024, three months to 2024-06-30$929.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure1,002Revenue, Q3 FY2024, three months to 2024-09-30$1.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure1,128Revenue, Q4 FY2024, three months to 2024-12-31$1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure1,117Revenue, Q1 FY2025, three months to 2025-03-31$1.12bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure1,315Revenue, Q2 FY2025, three months to 2025-06-30$1.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure1,412Revenue, Q3 FY2025, three months to 2025-09-30$1.41bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure1,498Revenue, Q4 FY2025, three months to 2025-12-31$1.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure1,513Revenue, Q1 FY2026, three months to 2026-03-31$1.51bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure1,705Revenue, Q2 FY2026, three months to 2026-06-30$1.71bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Cost of revenue$m96.3Cost of revenue, Q3 FY2023, three months to 2023-09-30$96.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$m685Gross profit, Q3 FY2023, three months to 2023-09-30$685.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure529Gross profit, Q4 FY2023, three months to 2023-12-31$528.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure627Gross profit, Q1 FY2024, three months to 2024-03-31$626.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure791Gross profit, Q2 FY2024, three months to 2024-06-30$791.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure831Gross profit, Q3 FY2024, three months to 2024-09-30$831.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure967Gross profit, Q4 FY2024, three months to 2024-12-31$967.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure952Gross profit, Q1 FY2025, three months to 2025-03-31$952.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure1,151Gross profit, Q2 FY2025, three months to 2025-06-30$1.15bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure1,216Gross profit, Q3 FY2025, three months to 2025-09-30$1.22bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure1,356Gross profit, Q4 FY2025, three months to 2025-12-31$1.36bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure1,346Gross profit, Q1 FY2026, three months to 2026-03-31$1.35bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure1,531Gross profit, Q2 FY2026, three months to 2026-06-30$1.53bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Research and development$m453Research and development, Q3 FY2023, three months to 2023-09-30$453.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure494Research and development, Q4 FY2023, three months to 2023-12-31$494.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure461Research and development, Q1 FY2024, three months to 2024-03-31$460.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure454Research and development, Q2 FY2024, three months to 2024-06-30$454.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure496Research and development, Q3 FY2024, three months to 2024-09-30$496.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure542Research and development, Q4 FY2024, three months to 2024-12-31$542.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure482Research and development, Q1 FY2025, three months to 2025-03-31$481.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure525Research and development, Q2 FY2025, three months to 2025-06-30$524.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure524Research and development, Q3 FY2025, three months to 2025-09-30$523.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure615Research and development, Q4 FY2025, three months to 2025-12-31$615.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure541Research and development, Q1 FY2026, three months to 2026-03-31$541.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure612Research and development, Q2 FY2026, three months to 2026-06-30$612.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Selling, general and administrative$m366Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$365.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure418Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$418.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure427Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$427.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure444Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$443.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure455Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$455.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure505Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$504.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure459Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$459.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure538Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$537.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure529Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$529.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure555Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$555.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure555Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$555.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure593Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$593.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Operating income$m(134)Operating income, Q3 FY2023, three months to 2023-09-30−$134.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure(384)Operating income, Q4 FY2023, three months to 2023-12-31−$383.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure(261)Operating income, Q1 FY2024, three months to 2024-03-31−$261.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure(107)Operating income, Q2 FY2024, three months to 2024-06-30−$107.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure(120)Operating income, Q3 FY2024, three months to 2024-09-30−$120.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure(79.4)Operating income, Q4 FY2024, three months to 2024-12-31−$79.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure11.1Operating income, Q1 FY2025, three months to 2025-03-31$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure87.9Operating income, Q2 FY2025, three months to 2025-06-30$87.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure163Operating income, Q3 FY2025, three months to 2025-09-30$163.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure185Operating income, Q4 FY2025, three months to 2025-12-31$185.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure250Operating income, Q1 FY2026, three months to 2026-03-31$249.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure325Operating income, Q2 FY2026, three months to 2026-06-30$325.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reported7.0Interest expense, Q1 FY2025, three months to 2025-03-31$7.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure8.0Interest expense, Q2 FY2025, three months to 2025-06-30$8.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figurenot reportednot reported32.9Interest expense, Q1 FY2026, three months to 2026-03-31$32.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure39.7Interest expense, Q2 FY2026, three months to 2026-06-30$39.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Income tax$m13.9Income tax, Q3 FY2023, three months to 2023-09-30$13.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure16.8Income tax, Q4 FY2023, three months to 2023-12-31$16.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure7.7Income tax, Q1 FY2024, three months to 2024-03-31$7.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure14.5Income tax, Q2 FY2024, three months to 2024-06-30$14.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure23.0Income tax, Q3 FY2024, three months to 2024-09-30$23.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure66.5Income tax, Q4 FY2024, three months to 2024-12-31$66.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure19.6Income tax, Q1 FY2025, three months to 2025-03-31$19.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure5.2Income tax, Q2 FY2025, three months to 2025-06-30$5.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure22.3Income tax, Q3 FY2025, three months to 2025-09-30$22.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure82.7Income tax, Q4 FY2025, three months to 2025-12-31$82.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure31.9Income tax, Q1 FY2026, three months to 2026-03-31$31.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure75.5Income tax, Q2 FY2026, three months to 2026-06-30$75.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Net income$m215Net income, Q3 FY2023, three months to 2023-09-30$215.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure(368)Net income, Q4 FY2023, three months to 2023-12-31−$367.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure(251)Net income, Q1 FY2024, three months to 2024-03-31−$251.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure(120)Net income, Q2 FY2024, three months to 2024-06-30−$120.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure(121)Net income, Q3 FY2024, three months to 2024-09-30−$121.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure(152)Net income, Q4 FY2024, three months to 2024-12-31−$151.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure1.3Net income, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure94.3Net income, Q2 FY2025, three months to 2025-06-30$94.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure125Net income, Q3 FY2025, three months to 2025-09-30$124.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure66.5Net income, Q4 FY2025, three months to 2025-12-31$66.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure227Net income, Q1 FY2026, three months to 2026-03-31$227.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure237Net income, Q2 FY2026, three months to 2026-06-30$237.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Diluted EPS$ per share0.15Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figurenot reported(0.19)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure(0.09)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure(0.09)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figurenot reported0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure0.06Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure0.08Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figurenot reported0.15Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure0.16Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Basic EPS$ per share0.16Basic EPS, Q3 FY2023, three months to 2023-09-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figurenot reported(0.19)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure(0.09)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure(0.09)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figurenot reported0.00Basic EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure0.07Basic EPS, Q2 FY2025, three months to 2025-06-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure0.09Basic EPS, Q3 FY2025, three months to 2025-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figurenot reported0.16Basic EPS, Q1 FY2026, three months to 2026-03-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure0.16Basic EPS, Q2 FY2026, three months to 2026-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure

Balance sheet

Cash and equivalents$5.10bn, Q2 FY2026
Long-term debt$882.2m, Q2 FY2026
Shareholders' equity$5.17bn, Q2 FY2026
BeOne Medicines Ltd., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m3,067Cash and equivalents, Q3 FY2023, at 2023-09-30$3.07bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure3,172Cash and equivalents, FY2023, at 2023-12-31$3.17bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure2,793Cash and equivalents, Q1 FY2024, at 2024-03-31$2.79bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure2,593Cash and equivalents, Q2 FY2024, at 2024-06-30$2.59bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure2,702Cash and equivalents, Q3 FY2024, at 2024-09-30$2.70bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure2,627Cash and equivalents, FY2024, at 2024-12-31$2.63bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure2,516Cash and equivalents, Q1 FY2025, at 2025-03-31$2.52bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure2,756Cash and equivalents, Q2 FY2025, at 2025-06-30$2.76bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure4,037Cash and equivalents, Q3 FY2025, at 2025-09-30$4.04bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure4,548Cash and equivalents, FY2025, at 2025-12-31$4.55bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure4,792Cash and equivalents, Q1 FY2026, at 2026-03-31$4.79bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure5,098Cash and equivalents, Q2 FY2026, at 2026-06-30$5.10bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Current assets$m4,054Current assets, Q3 FY2023, at 2023-09-30$4.05bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure4,203Current assets, FY2023, at 2023-12-31$4.20bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001651308-25-000031.Report this figure3,908Current assets, Q1 FY2024, at 2024-03-31$3.91bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure3,839Current assets, Q2 FY2024, at 2024-06-30$3.84bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure3,912Current assets, Q3 FY2024, at 2024-09-30$3.91bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure3,992Current assets, FY2024, at 2024-12-31$3.99bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure3,896Current assets, Q1 FY2025, at 2025-03-31$3.90bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure4,310Current assets, Q2 FY2025, at 2025-06-30$4.31bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure5,664Current assets, Q3 FY2025, at 2025-09-30$5.66bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure6,234Current assets, FY2025, at 2025-12-31$6.23bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure6,601Current assets, Q1 FY2026, at 2026-03-31$6.60bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure7,216Current assets, Q2 FY2026, at 2026-06-30$7.22bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Total assets$m5,525Total assets, Q3 FY2023, at 2023-09-30$5.52bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure5,805Total assets, FY2023, at 2023-12-31$5.81bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001651308-25-000031.Report this figure5,668Total assets, Q1 FY2024, at 2024-03-31$5.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure5,712Total assets, Q2 FY2024, at 2024-06-30$5.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure5,831Total assets, Q3 FY2024, at 2024-09-30$5.83bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure5,921Total assets, FY2024, at 2024-12-31$5.92bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure5,842Total assets, Q1 FY2025, at 2025-03-31$5.84bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure6,298Total assets, Q2 FY2025, at 2025-06-30$6.30bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure7,633Total assets, Q3 FY2025, at 2025-09-30$7.63bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure8,189Total assets, FY2025, at 2025-12-31$8.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure8,554Total assets, Q1 FY2026, at 2026-03-31$8.55bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure9,176Total assets, Q2 FY2026, at 2026-06-30$9.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Current liabilities$m1,283Current liabilities, Q3 FY2023, at 2023-09-30$1.28bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure1,810Current liabilities, FY2023, at 2023-12-31$1.81bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001651308-25-000031.Report this figure1,882Current liabilities, Q1 FY2024, at 2024-03-31$1.88bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure1,939Current liabilities, Q2 FY2024, at 2024-06-30$1.94bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure2,025Current liabilities, Q3 FY2024, at 2024-09-30$2.03bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure2,215Current liabilities, FY2024, at 2024-12-31$2.21bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure1,984Current liabilities, Q1 FY2025, at 2025-03-31$1.98bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure2,210Current liabilities, Q2 FY2025, at 2025-06-30$2.21bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure2,368Current liabilities, Q3 FY2025, at 2025-09-30$2.37bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure1,829Current liabilities, FY2025, at 2025-12-31$1.83bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure1,812Current liabilities, Q1 FY2026, at 2026-03-31$1.81bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure2,119Current liabilities, Q2 FY2026, at 2026-06-30$2.12bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Total liabilities$m1,762Total liabilities, Q3 FY2023, at 2023-09-30$1.76bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure2,268Total liabilities, FY2023, at 2023-12-31$2.27bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001651308-25-000031.Report this figure2,307Total liabilities, Q1 FY2024, at 2024-03-31$2.31bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure2,346Total liabilities, Q2 FY2024, at 2024-06-30$2.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure2,395Total liabilities, Q3 FY2024, at 2024-09-30$2.39bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure2,589Total liabilities, FY2024, at 2024-12-31$2.59bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure2,342Total liabilities, Q1 FY2025, at 2025-03-31$2.34bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure2,528Total liabilities, Q2 FY2025, at 2025-06-30$2.53bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure3,503Total liabilities, Q3 FY2025, at 2025-09-30$3.50bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure3,827Total liabilities, FY2025, at 2025-12-31$3.83bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure3,793Total liabilities, Q1 FY2026, at 2026-03-31$3.79bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure4,002Total liabilities, Q2 FY2026, at 2026-06-30$4.00bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Long-term debt$m202Long-term debt, Q3 FY2023, at 2023-09-30$202.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure198Long-term debt, FY2023, at 2023-12-31$197.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-27, accession 0001651308-25-000031.Report this figure199Long-term debt, Q1 FY2024, at 2024-03-31$199.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure185Long-term debt, Q2 FY2024, at 2024-06-30$185.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure188Long-term debt, Q3 FY2024, at 2024-09-30$187.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure166Long-term debt, FY2024, at 2024-12-31$166.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure160Long-term debt, Q1 FY2025, at 2025-03-31$160.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure146Long-term debt, Q2 FY2025, at 2025-06-30$146.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figurenot reported962Long-term debt, FY2025, at 2025-12-31$961.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure963Long-term debt, Q1 FY2026, at 2026-03-31$962.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure882Long-term debt, Q2 FY2026, at 2026-06-30$882.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Current portion of debt$m329Current portion of debt, Q3 FY2023, at 2023-09-30$328.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure688Current portion of debt, FY2023, at 2023-12-31$688.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-27, accession 0001651308-25-000031.Report this figure827Current portion of debt, Q1 FY2024, at 2024-03-31$827.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure852Current portion of debt, Q2 FY2024, at 2024-06-30$851.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure864Current portion of debt, Q3 FY2024, at 2024-09-30$863.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure852Current portion of debt, FY2024, at 2024-12-31$851.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure763Current portion of debt, Q1 FY2025, at 2025-03-31$763.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure808Current portion of debt, Q2 FY2025, at 2025-06-30$808.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figurenot reported57.3Current portion of debt, FY2025, at 2025-12-31$57.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure116Current portion of debt, Q1 FY2026, at 2026-03-31$116.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure191Current portion of debt, Q2 FY2026, at 2026-06-30$190.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reported852Short-term borrowings, FY2024, at 2024-12-31$851.5m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figurenot reportednot reported813Short-term borrowings, Q3 FY2025, at 2025-09-30$813.3m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure9.1Short-term borrowings, FY2025, at 2025-12-31$9.1m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure9.3Short-term borrowings, Q1 FY2026, at 2026-03-31$9.3m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure71.2Short-term borrowings, Q2 FY2026, at 2026-06-30$71.2m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure
Shareholders' equity$m3,763Shareholders' equity, Q3 FY2023, at 2023-09-30$3.76bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure3,537Shareholders' equity, FY2023, at 2023-12-31$3.54bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001628280-26-011946.Report this figure3,360Shareholders' equity, Q1 FY2024, at 2024-03-31$3.36bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure3,366Shareholders' equity, Q2 FY2024, at 2024-06-30$3.37bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure3,436Shareholders' equity, Q3 FY2024, at 2024-09-30$3.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure3,332Shareholders' equity, FY2024, at 2024-12-31$3.33bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure3,500Shareholders' equity, Q1 FY2025, at 2025-03-31$3.50bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure3,770Shareholders' equity, Q2 FY2025, at 2025-06-30$3.77bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure4,129Shareholders' equity, Q3 FY2025, at 2025-09-30$4.13bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure4,361Shareholders' equity, FY2025, at 2025-12-31$4.36bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure4,760Shareholders' equity, Q1 FY2026, at 2026-03-31$4.76bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure5,174Shareholders' equity, Q2 FY2026, at 2026-06-30$5.17bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure

Cash flow

Operating cash flow$462.8m, Q2 FY2026
Capital expenditure$27.5m, Q2 FY2026
BeOne Medicines Ltd., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(78.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$78.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001651308-24-000152. Derived: 9-month figure less the 6-month figure.Report this figure(222)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$221.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure(309)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$308.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure(95.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$95.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001651308-25-000133. Derived: 6-month figure less the 3-month figure.Report this figure188Operating cash flow, Q3 FY2024, three months to 2024-09-30$188.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001628280-25-049824. Derived: 9-month figure less the 6-month figure.Report this figure75.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$75.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure44.1Operating cash flow, Q1 FY2025, three months to 2025-03-31$44.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure264Operating cash flow, Q2 FY2025, three months to 2025-06-30$263.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001628280-26-052878. Derived: 6-month figure less the 3-month figure.Report this figure403Operating cash flow, Q3 FY2025, three months to 2025-09-30$402.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001628280-25-049824. Derived: 9-month figure less the 6-month figure.Report this figure417Operating cash flow, Q4 FY2025, three months to 2025-12-31$417.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure201Operating cash flow, Q1 FY2026, three months to 2026-03-31$201.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure463Operating cash flow, Q2 FY2026, three months to 2026-06-30$462.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001628280-26-052878. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m158Capital expenditure, Q3 FY2023, three months to 2023-09-30$157.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001651308-24-000152. Derived: 9-month figure less the 6-month figure.Report this figure157Capital expenditure, Q4 FY2023, three months to 2023-12-31$157.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure157Capital expenditure, Q1 FY2024, three months to 2024-03-31$156.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure110Capital expenditure, Q2 FY2024, three months to 2024-06-30$110.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001651308-25-000133. Derived: 6-month figure less the 3-month figure.Report this figure134Capital expenditure, Q3 FY2024, three months to 2024-09-30$133.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-049824. Derived: 9-month figure less the 6-month figure.Report this figure92.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$92.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure56.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$56.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure43.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$43.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001628280-26-052878. Derived: 6-month figure less the 3-month figure.Report this figure48.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$48.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-049824. Derived: 9-month figure less the 6-month figure.Report this figure37.5Capital expenditure, Q4 FY2025, three months to 2025-12-31$37.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-011946. Derived: 12-month figure less the 9-month figure.Report this figure40.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$40.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure27.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$27.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001628280-26-052878. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)1.51bn, Q2 FY2026
BeOne Medicines Ltd., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1,345Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,345,303,747 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001651308-23-000165.Report this figure1,354Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,354,164,760 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001651308-24-000051.Report this figure1,360Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,360,224,377 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001651308-24-000098.Report this figure1,390Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,390,331,833 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001651308-24-000152.Report this figure1,356Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,355,547,626 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001651308-25-000075.Report this figure1,361Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,361,082,567 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001651308-25-000133.Report this figure1,377Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,376,751,873 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure1,445Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,445,253,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure1,463Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,463,277,401 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure1,489Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,488,750,354 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001628280-25-049824.Report this figure1,505Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,505,027,338 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-030867.Report this figure1,505Diluted shares (weighted), Q2 FY2026, three months to 2026-06-301,505,361,900 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure

Shares outstanding: 1.48bnShares outstanding, period not labelled, at 2026-07-311,478,124,405 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001628280-26-052878.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.